Peraza Lisa 4
4 · HERON THERAPEUTICS, INC. /DE/ · Filed Jul 17, 2023
Insider Transaction Report
Form 4
Peraza Lisa
VP, Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2023-07-13+1,933→ 26,170 total - Exercise/Conversion
Common Stock
2023-07-13+552→ 24,237 total - Exercise/Conversion
Restricted Stock Units
2023-07-13−552→ 2,760 total→ Common Stock (552 underlying) - Exercise/Conversion
Restricted Stock Units
2023-07-13−1,933→ 9,896 total→ Common Stock (1,933 underlying) - Tax Payment
Common Stock
2023-07-13$1.31/sh−860$1,127→ 25,310 total
Footnotes (4)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.
- [F3]The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).
- [F4]The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).